Henry Schein, Inc. company logo

# 1st Gen Model Henry Schein, Inc. Medical & hospital equipment

Subscribe >> Deal exit on
July 21, 2017
Deal entry on
July 21, 2017
0.18%Expected margin
77.03% successful of 74 deals
$184.92 Last close price
at 21-jul-2017

HSIC

Model's trade recommendations 5.12% Return for period

14.51% Annual return

$14.69B Market Cap

β 1.09  

HSIC

Model (following trade recommendations)

HSIC

Underlying stock

S&P 500

Index
Return for period 5.12%
0.41%
1.78%
52wk return 7.34%
2.36%
16.82%
52wk Range
147.04—186.57
2000.54—2399.63
Sortino ratio 2.37
Sharpe ratio 1.55
Norm. RMSE 0.15%
Downside risk 5.74%
Volatility 8.78%
  • BUY Analysts consensus recommendation

Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. The company conducts its business principally through two segments; healthcare distribution and technology. These segments, which are operated as individual business units, offer different products and services, albeit to the same customer base. The healthcare distribution segment consists of the company's dental, medical, veterinary and international groups.

Industry sector: Medical

Sector classification: Medical & hospital equipment

Deep Learning based analysis and prediction model for Henry Schein, Inc. (HSIC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for HSIC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 78M
P/E 26.61
Shares Outstanding 79M
% Held by Insiders 1.27%
% Held by Institutions 90.74%
EPS (last reported FY) $6.61
EPS (last reported Q) $1.76
EPS, estimated (last reported Q) $1.66
Total revenues $12 B
Net income $1 B